Showing 1341-1350 of 1697 results for "".
- Muscular Dystrophy Association Launches Data Reporting and Visualization Platform for Neuromuscular Diseasehttps://practicalneurology.com/news/muscular-dystrophy-association-launches-data-reporting-and-visualization-platform-for-neuromuscular-disease/2469411/The Muscular Dystrophy Association (MDA) has announced the availability of its new data sharing platform, the neuromuscular observational research (MOVR) visualization and reporting platform (VRP). MOVR-VRP represents a milestone in advancing neuromuscular disease research and improving patient c
- Anticholinergics May be Associated With Increased Risk of Mild Cognitive Impairmenthttps://practicalneurology.com/news/anticholinergics-may-be-associated-with-increased-risk-of-mild-cognitive-impairment/2469368/According to a study published in Neurology, an increase of risk developing mild cognitive impairment (MCI) may be associated with use of anticholinergic medications. The cognitive decline is shown in individuals with genetic conditions for Alzheimer disease (AD) or markers of this condition,&nbs
- FDA Approves ppCBD to Treat Seizures Associated with Tuberous Sclerosis Complexhttps://practicalneurology.com/news/fda-approves-ppcbd-to-treat-seizures-associated-with-tuberous-sclerosis-complex/2469341/The Food and Drug Administration (FDA) has approved prescription pharmaceutical cannabidiol (ppCBD) (Epidiolex; GW Pharmaceuticals, Carlsbad, CA) oral solution to treat seizures associated with tuberous sclerosis complex (TSC) in patients age 1 year or more. Along with this new indication, the ag
- FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndromehttps://practicalneurology.com/news/fda-approves-fenfluramine-for-treatment-of-seizures-associated-with-dravet-syndrome/2469308/The Food and Drug Administration (FDA) has approved fenfluramine (Fintepla; Zogenix, Emeryville, CA), oral solution for treatment of seizures associated with Dravet syndrome (DS) in individuals age 2 years or more. Fenfluramine will be launched through a restricted distribution program, called th
- May 1 Facebook Live Session on ALS Sponsored by Muscular Dystrophy Associationhttps://practicalneurology.com/news/may-1-facebook-live-session-on-als-sponsored-by-muscular-dystrophy-association/2469236/To mark the beginning of amyotrophic lateral sclerosis (ALS) awareness month, the Muscular Dystrophy Association (ALS) is sponsoring a special virtual conversation on Facebook Live about best practices and precautions for people with ALS during the COVID-19 pandemic. The Facebook Live event
- Muscular Dystrophy Association Launches Survey to Prioritize Needs During Pandemichttps://practicalneurology.com/news/muscular-dystrophy-association-launches-survey-to-prioritize-needs-during-pandemic/2469231/Even during the COVID-19 pandemic, efforts are being made to best serve the neuromuscular community. A survey was launched by the Muscular Dystrophy Association for the neuromuscular disability community, including caregivers. The survey has 10 questions and designed to identify the most pressing
- Sleep Bruxism, or Teeth Grinding at Night, May Be Associated With Restless Leg Syndromehttps://practicalneurology.com/news/sleep-bruxism-or-teeth-grinding-at-night-may-be-associaed-with-restless-leg-syndrome/2468924/Data presented at the SLEEP2019 meeting support a strong association between restless leg syndrome (RLS) and sleep bruxism (SB; also known as teeth grinding). Both are movement disorders and parasomnias and this connection suggests that bruxism might respond to treatment with dopamine agonists (D
- New Alzheimer's Association Campaign Facilitates and Encourages Communication About Cognitive Issueshttps://practicalneurology.com/news/new-alzheimers-association-campaign-facilitates-encourages-early-family-communication-about-cognitive-issues/2468914/The Alzheimer’s Association has released results of a new survey showing that although 90% of people want to be told by family members if they seem to have cognitive problems, only 25% of people say they would be comfortable initiating that conversation. Often the first to notice memory iss
- Hearing Impairment Associated with AD Risk, Cognitive Decline, Brain Structure Changes, and Tau Pathologyhttps://practicalneurology.com/news/hearing-impairment-associated-with-ad-risk-cognitive-decline-brain-structure-changes-and-tau-pathology/2470244/A study presented at the 2023 meeting of the Alzheimer’s Association International Conference (AAIC) found that hearing impairment is a risk factor for the development of Alzheimer disease (AD) and is associated with
- Significant Association Found Between New Opioid Use and Mortality in Patients with Dementia According to Researchershttps://practicalneurology.com/news/significant-association-found-between-new-opioid-use-and-mortality-in-patients-with-dementia-according-to-researchers/2470242/Exposure to new opioid use was associated with significantly increased excess mortality, according to research presented at the 2023 meeting of the Alzheimer’s Association International Conference (AAIC). Researchers